(ACWI) MSCI ACWI - Overview
Etf: Stocks, Developed, Emerging, Global, Equities
Dividends
| Dividend Yield | 1.65% |
| Yield on Cost 5y | 2.52% |
| Yield CAGR 5y | 4.92% |
| Payout Consistency | 96.9% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 13.9% |
| Relative Tail Risk | 4.46% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.99 |
| Alpha | 7.87 |
| Character TTM | |
|---|---|
| Beta | 0.869 |
| Beta Downside | 0.865 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.55% |
| CAGR/Max DD | 1.18 |
Description: ACWI MSCI ACWI December 19, 2025
The iShares MSCI ACWI ETF (NASDAQ: ACWI) aims to track the MSCI ACWI Index by allocating at least 80 % of its assets to the index’s constituent securities or to securities that are economically equivalent, using a free-float-adjusted market-cap weighting scheme that spans both developed and emerging markets.
Key data points (as of Q4 2024): the fund carries an expense ratio of 0.32 % and manages roughly $30 billion in assets; its sector exposure is dominated by Technology (~22 %), Financials (~15 %) and Health Care (~13 %). Geographically, about 55 % of holdings are U.S. equities, 30 % are other developed-market stocks, and the remaining 15 % represent emerging-market exposure. Performance is closely tied to global GDP growth trends, corporate earnings cycles, and currency movements between the U.S. dollar and major foreign currencies.
For a deeper dive into ACWI’s risk-adjusted return profile and how it fits into a diversified global allocation, you might find ValueRay’s analytical tools useful.
What is the price of ACWI shares?
Over the past week, the price has changed by +0.54%, over one month by +1.34%, over three months by +5.90% and over the past year by +21.58%.
Is ACWI a buy, sell or hold?
What are the forecasts/targets for the ACWI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 171.8 | 17.4% |
ACWI Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 26.54b USD (26.54b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 26.54b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 26.54b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.12% (E(26.54b)/V(26.54b) * Re(9.12%) + (debt-free company))
Discount Rate = 9.12% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)